Allergan's Botox gets FDA OK to treat forehead lines
Allergan PLC (AGN) said Tuesday that the Food and Drug Administration has approved Botox for the temporary improvement of moderate-to-severe forehead lines. Botox is already approved for treat "crow's feet" and glabellar lines. Allergan's stock, which was still inactive in premarket trade, has tumbled 13.5% over the past three months, to be up just 0.5% year to date, while the S&P 500 has gained 4.1% over the past three months and 13.0% this year.
-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires